Dashboard
Manage Tickers

AVTAAVANTAX, INC.

Nasdaq blucora.com


$ 26.00 $ -0.01 (-0.04 %)    

Monday, 27-Nov-2023 15:59:52 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 442.72 $ -0.69 (-0.16 %)
DIA $ 395.06 $ -1.32 (-0.33 %)
SPY $ 520.78 $ -1.81 (-0.35 %)
TLT $ 90.40 $ 0.07 (0.08 %)
GLD $ 215.88 $ -2.82 (-1.29 %)
$ 25.99
$ 26.00
$ 0.00 x 0
$ 0.00 x 0
$ 25.99 - $ 26.00
$ 19.13 - $ 30.23
826,494
na
959.58M
$ 1.49
$ 2.58
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2023 09-30-2023 10-Q
2 08-09-2023 06-30-2023 10-Q
3 05-08-2023 03-31-2023 10-Q
4 02-28-2023 12-31-2022 10-K
5 11-01-2022 09-30-2022 10-Q
6 08-08-2022 06-30-2022 10-Q
7 05-04-2022 03-31-2022 10-Q
8 02-25-2022 12-31-2021 10-K
9 11-04-2021 09-30-2021 10-Q
10 08-04-2021 06-30-2021 10-Q
11 05-05-2021 03-31-2021 10-Q
12 02-26-2021 12-31-2020 10-K
13 11-09-2020 09-30-2020 10-Q
14 08-05-2020 06-30-2020 10-Q
15 05-06-2020 03-31-2020 10-Q
16 02-28-2020 12-31-2019 10-K
17 11-06-2019 09-30-2019 10-Q
18 08-08-2019 06-30-2019 10-Q
19 05-08-2019 03-31-2019 10-Q
20 03-01-2019 12-31-2018 10-K
21 10-31-2018 09-30-2018 10-Q
22 08-01-2018 06-30-2018 10-Q
23 05-09-2018 03-31-2018 10-Q
24 03-01-2018 12-31-2017 10-K
25 10-26-2017 09-30-2017 10-Q
26 07-27-2017 06-30-2017 10-Q
27 05-04-2017 03-31-2017 10-Q
28 02-28-2017 12-31-2016 10-K
29 10-27-2016 09-30-2016 10-Q
30 07-28-2016 06-30-2016 10-Q
31 04-28-2016 03-31-2016 10-Q
32 02-24-2016 12-31-2015 10-K
33 10-29-2015 09-30-2015 10-Q
34 07-30-2015 06-30-2015 10-Q
35 04-30-2015 03-31-2015 10-Q
36 02-26-2015 12-31-2014 10-K
37 11-05-2014 09-30-2014 10-Q
38 08-07-2014 06-30-2014 10-Q
39 05-01-2014 03-31-2014 10-Q
40 02-27-2014 12-31-2013 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

avantax-q3-eps-036-beats-019-estimate-sales-19234m-beat-19190m-estimate
Avantax Q3 EPS $0.36 Beats $0.19 Estimate,...
11/06/2023 12:35:51

Avantax (NASDAQ:AVTA) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.19 by 89.4...

top-4-financial-stocks-that-may-collapse-this-quarter
Top 4 Financial Stocks That May Collapse T...
11/03/2023 11:33:26

The most overbought stocks in the financial sector presents an opportunity to go short on these overvalued companies.

barrington-research-downgrades-avantax-to-market-perform
Barrington Research Downgrades Avantax to ...
09/12/2023 16:00:33

Barrington Research analyst Alexander Paris downgrades Avantax (NASDAQ:AVTA) from Outperform to Market Perform.

benzingas-top-ratings-upgrades-downgrades-for-september-12-2023
Benzinga's Top Ratings Upgrades, Downgrade...
09/12/2023 15:00:43

5-analysts-have-this-to-say-about-avantax
5 Analysts Have This to Say About Avantax
09/12/2023 13:01:31

cantor-fitzgerald-downgrades-avantax-to-neutral-lowers-price-target-to-26
Cantor Fitzgerald Downgrades Avantax to Ne...
09/12/2023 08:28:39

Cantor Fitzgerald analyst Josh Siegler downgrades Avantax (NASDAQ:AVTA) from Overweight to Neutral and lowers the price targ...

nasdaq-rises-over-1-hostess-brands-shares-spike-higher
Nasdaq Rises Over 1%; Hostess Brands Share...
09/11/2023 18:31:35

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Monday. The Dow traded ...

why-avantax-shares-are-trading-higher-by-over-27-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Avantax Shares Are Trading Higher By O...
09/11/2023 17:38:46

Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltuso...

gold-edges-higher-virco-manufacturing-shares-surge-after-q2-results
Gold Edges Higher; Virco Manufacturing Sha...
09/11/2023 16:03:13

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 80 points on Monday. The Dow traded...

william-blair-downgrades-avantax-to-market-perform
William Blair Downgrades Avantax to Market...
09/11/2023 15:43:40

William Blair analyst Jeff Schmitt downgrades Avantax (NASDAQ:AVTA) from Outperform to Market Perform.

cash-windfall-for-avantax-stockholders---stock-jumps-on-buyout-deal
Cash Windfall For Avantax Stockholders - S...
09/11/2023 14:00:20

Avantax Inc. (NASDAQ: AVTA) has agreed to be acquired by Cetera Holdings for about

avantax-shares-resume-trade
Avantax Shares Resume Trade
09/11/2023 13:00:56

avantax-enters-definitive-agreement-to-be-acquired-by-cetera-holdings-for-26share-in-cash
Avantax Enters Definitive Agreement To Be ...
09/11/2023 12:31:57

avantax-acquires-summit-wealth-advocates-adding-7-person-team-and-330m-in-total-client-assets-to-avantaxs-employee-based-model
Avantax Acquires Summit Wealth Advocates A...
08/22/2023 13:17:18

avantax-recruiting-outlook-remains-strong-as-tax-and-financial-professionals-seek-faster-growth-and-superior-service-during-q2-avantax-reported-newly-recruited-assets-of-141m
Avantax Recruiting Outlook Remains Strong ...
08/15/2023 13:20:43

Avantax®, a leader in tax-focused financial planning and wealth management, welcomed more than 100 independent Financial Profes...

cantor-fitzgerald-maintains-overweight-on-avantax-lowers-price-target-to-27
Cantor Fitzgerald Maintains Overweight on ...
08/11/2023 17:56:10

Cantor Fitzgerald analyst Josh Siegler maintains Avantax (NASDAQ:AVTA) with a Overweight and lowers the price target from $2...

benchmark-maintains-buy-on-avantax-lowers-price-target-to-30
Benchmark Maintains Buy on Avantax, Lowers...
08/11/2023 16:27:57

Benchmark analyst Daniel Kurnos maintains Avantax (NASDAQ:AVTA) with a Buy and lowers the price target from $32 to $30.

barrington-research-reiterates-outperform-on-avantax-lowers-price-target-to-30
Barrington Research Reiterates Outperform ...
08/10/2023 17:45:58

Barrington Research analyst Alexander Paris reiterates Avantax (NASDAQ:AVTA) with a Outperform and lowers the price target f...

avantax-tightens-fy23-revenue-outlook-from-750m-758m-to-753m-756m--consensus-75533m-sees-adj-eps-122-130
Avantax Tightens FY23 Revenue Outlook From...
08/09/2023 20:45:36

avantax-q2-adj-eps-036-beats-014-estimate-sales-18693m-miss-18887m-estimate
Avantax Q2 Adj EPS $0.36 Beats $0.14 Estim...
08/09/2023 20:08:30

Avantax (NASDAQ:AVTA) reported quarterly adj earnings of $0.36 per share which beat the analyst consensus estimate of $0.14 by ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION